| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/2010 | CN101622010A Sugar immunogens |
| 01/06/2010 | CN101622009A Influenza vaccine formulation |
| 01/06/2010 | CN101622008A Papillomavirus vaccine compositions |
| 01/06/2010 | CN101618213A Combined attenuated live vaccine for measles, mumps and encephalitis B and preparation method thereof |
| 01/06/2010 | CN101618212A Gene vaccine of tuberculosis multivalence epitope and application thereof |
| 01/06/2010 | CN101618211A Hepatitis B polypeptide vaccine and application thereof |
| 01/06/2010 | CN101618049A Treatment of neoplasms with viruses |
| 01/06/2010 | CN100578227C TTK in diagnosis and as a therapeutic target in cancer |
| 01/06/2010 | CN100577804C Novel mutant allergens |
| 01/06/2010 | CN100577803C transgenic animal for expressing Alzheimer tau protein |
| 01/06/2010 | CN100577683C Infectious cDNA of an approved vaccine strain of measles virus, use for the same used as immunogenic compositions |
| 01/06/2010 | CN100577212C Function of E4BP4 gene in embryo implantation course and application thereof |
| 01/06/2010 | CN100577205C Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions prepared therefrom |
| 01/06/2010 | CN100577204C Method for producing swine fever live vaccine with cell line |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642341 Antibody fragments are selected from Fab fragments, Fv fragments, single domain antigen binding fragments, scFv and aggregates thereof; for treatment of solid tumor carcinomas |
| 01/05/2010 | US7642238 Using soluble frizzled related protein 3 (SFRP-3) and/or Dickkopf-1 (DKK1) expression profiles as evaluative tools in prediciting/diagnosing bone disorders in cancer patients |
| 01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
| 01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 01/05/2010 | US7642051 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 01/05/2010 | US7642045 Antibodies to protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells |
| 01/05/2010 | US7641911 Immunological adjuvant compositions |
| 01/05/2010 | US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641908 Dengue serotype 2 attenuated strain |
| 01/05/2010 | US7641907 site-directed mutagenesis; immunogens; vaccines |
| 01/05/2010 | US7641906 Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641904 IL-32 monoclonal antibodies and uses thereof |
| 01/05/2010 | US7641903 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant |
| 01/05/2010 | US7641902 Detecting vimentin expression and secretion and for characterizing cancer ( prostate cancer); |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641896 Adjuvant viral particle |
| 01/05/2010 | US7641895 Peptides for active anti-cytokine immunization |
| 01/05/2010 | US7641891 Chimeric, human and humanized anti-CSAp monoclonal antibodies |
| 01/05/2010 | CA2592555C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2260759C Recombinant swinepox virus |
| 01/05/2010 | CA2175375C Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 12/31/2009 | US20090327170 Methods of Clustering Gene and Protein Sequences |
| 12/31/2009 | US20090326614 Shape Tunable Plasmonic Nanoparticles |
| 12/31/2009 | US20090326607 Electrical Stimulation Method for Treatment of Peripheral Neuropathy |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326200 Altered ospa of borrelia burgdorferi |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090325886 Wt1 modified peptide |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325259 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 12/31/2009 | US20090324723 Method of prophylaxis of infection |
| 12/31/2009 | US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 12/31/2009 | US20090324702 Novel viral vector |
| 12/31/2009 | US20090324700 Methods and compositions for the inhibition of cathepsins |
| 12/31/2009 | US20090324677 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 12/31/2009 | US20090324651 Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System |
| 12/31/2009 | US20090324650 Method for The Production of Hydrolyzed Allergen |
| 12/31/2009 | US20090324649 Leishmania vaccine using sand fly salivary immunogen |
| 12/31/2009 | US20090324648 Vaccine for edwardsiella disease and streptococcal disease in fish |
| 12/31/2009 | US20090324647 Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use |
| 12/31/2009 | US20090324646 Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression |
| 12/31/2009 | US20090324645 Production of vaccines |
| 12/31/2009 | US20090324644 Chimeric vaccine antigens against the avian influenza virus |
| 12/31/2009 | US20090324643 Compositions and methods for treating and preventing infection |
| 12/31/2009 | US20090324642 Method of elicting or inducing an immune response |
| 12/31/2009 | US20090324641 Novel adjuvant compositions |
| 12/31/2009 | US20090324640 Neuraminidase-deficient live influenza vaccines |
| 12/31/2009 | US20090324639 Compositions and methods for activating innate and allergic immunity |
| 12/31/2009 | US20090324638 Live bacterial vaccine |
| 12/31/2009 | US20090324634 Trypanosoma Antigens, Vaccine Compositions, and Related Methods |
| 12/31/2009 | US20090324633 Immunogens from Uropathogenic Escherichia Coli |
| 12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 12/31/2009 | US20090324631 Polyvalent Vaccine |
| 12/31/2009 | US20090324630 Fusion multiviral chimeric antigen |
| 12/31/2009 | US20090324629 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof |
| 12/31/2009 | US20090324628 Compounds useful in the diagnosis and treatment of malaria |
| 12/31/2009 | US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES |
| 12/31/2009 | US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
| 12/31/2009 | US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 12/31/2009 | US20090324624 Chitin micro-particles as an adjuvant |
| 12/31/2009 | US20090324623 Two-component genome flavivirus and uses thereof |
| 12/31/2009 | US20090324622 Antibody vaccine conjugates and uses therefor |
| 12/31/2009 | US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 12/31/2009 | US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 12/31/2009 | US20090324619 Immunogenic Protein Carrier Containing An Antigen Presenting Cell Binding Domain and A Cysteine-Rich Domain |
| 12/31/2009 | US20090324618 Novel signature self renewal gene expression programs |
| 12/31/2009 | US20090324617 Cancer specific glycans and use thereof |
| 12/31/2009 | US20090324616 Differential cytokine expression in human cancer |
| 12/31/2009 | US20090324615 Methods and compositions for modulating t cell and/or b cell activation |
| 12/31/2009 | US20090324614 Fc receptor binding proteins |
| 12/31/2009 | US20090324613 Compositions and Methods for the Therapy and Diagnosis of Cytomegalovirus |
| 12/31/2009 | US20090324612 Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule |
| 12/31/2009 | US20090324611 Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases |
| 12/31/2009 | US20090324610 Gene associated with arteriosclerotic disease, and use thereof |
| 12/31/2009 | US20090324609 Method of treating autoimmune disease with mesenchymal stem cells |
| 12/31/2009 | US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof |
| 12/31/2009 | US20090324607 Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts |
| 12/31/2009 | US20090324606 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/31/2009 | US20090324605 Interferon alpha antibodies and their uses |
| 12/31/2009 | US20090324604 M-csf specific monoclonal antibody and uses thereof |
| 12/31/2009 | US20090324603 Met fab and scfv fragments and methods of use |